photonamic GmbH & Co. KG

MolecuLight specializes in innovative imaging solutions for wound care, focusing on the detection of harmful bacteria and accurate wound measurement. The company develops portable handheld optical imaging devices that allow medical practitioners to visualize bacteria and assess wound status directly at the point of care. These devices facilitate the analysis and visual detection of bacteria, provide procedural guidance, and enable the assessment of viable and nonviable tissue. By offering these capabilities, MolecuLight supports healthcare professionals in selecting appropriate therapies for their patients and effectively monitoring wound healing progress.

NX Development Corp. is a life sciences company based in Lexington, Kentucky, established in 2010. It specializes in the development of Gleolan, an optical imaging agent designed to assist neurosurgeons in the visualization of malignant tissue during surgeries for gliomas, particularly glioblastoma. Gleolan aims to enhance the precision and extent of tumor resection while maintaining manageable costs for hospitals and favorable cost-benefit characteristics for payers. The product is used in conjunction with fluorescence add-on kits from leading surgical microscope manufacturers, providing an effective solution that minimizes medical risk while improving surgical outcomes. NX Development Corp. operates as a subsidiary of photonamic GmbH & Co. KG.